Company details

Company name Lucero
Company type Micro Enterprise (less than 10 employees and revenues less than 2 MEUR)
Industry sector Medical
Activity description

Lucero was founded in March 2020 in response to industry needs linked to the implementation of 3D cell cultures in early-stage pharmaceutical drug discovery processes. Their solution aims to tackle key challenges surrounding 3D-cell-culture handling, miniaturization, and assay preparation.

Company website

Project information

Technology platform TP-1: Free-space photonic components and systems
Application domain Biomedical
Project scope

A feasibility study towards the miniaturization of the current configuration of their single-sell manipulation tool, by reducing its size and weight, while keeping the same performance.

Project leader Dr. Ir. Lien Smeesters (VUB)
Project start March 2021
Project duration 3 months